Register by May 31 to Save Up to $500 off the standard rates
» View Pricing
Time is Money
Special Hotel Rate
THE Industry Meeting Place to Exchange Real-World Solutions to Improve Speed, Cost and Quality
Conference: September 16-19, 2013 · Exhibition: September 17-19, 2013 ·
Lowest Rates Now Available Until May 31 - Save $500
"A great opportunity for industrial networking." - Joerg Von Hagen, R&D Manager, Merck
The Evolution of BioProcess International
See the industry advacements disscuessed at BPI over the past ten years.
"This conference is both a great opportunity for 'newbies' in the field to get a great perspective as well as 'veterans' to have a forum for sharing the latest advances and learnings." - Elizabeth C. Dodson, BD Biosciences
"BPI is a great opportunity to meet leaders, and innovators in this industry." - Holzer Margit, VP R&D and Technology, Novasep
"This conference is always a great opportunity to get a very comprehensive overview on new trends in biologics process development, manufacturing aspects and new trends in the biologics business." - Wolfgang Noe, Ph.D., Vice President, Bioprocess Development, Biogen Idec
Continue to Connect and Communicate with your Peers All Year Round
Follow us on Twitter
Connect on Facebook
2012 Event Wrap-Up
Over 1,500 members of the bioprocessing industry gathered in Providence, RI for an interactive week of learning, networking and collaboration.
Take Part in BPI 2013
Where Industry Connects to Share Technical, Scientific and Strategic Solutions across All Phases of Bioprocess Development
Now celebrating its 10th Anniversary, BPI attracts experts from all bioprocessing and biomanufacturing disciplines and all levels, from research scientist to group leader to senior level executive who share and discuss their challenges in an interactive, learning environment.
PREPARE your bioprocessing operations for...
Perspectives from Visionary Keynote Speakers
Producing High Quality, Low Cost Biotherapeutics in the Century of Biology
James Thomas, Ph.D. / Amgen, Inc. Vice President, Process and Product Development and WA Site Head
Transforming the Development of Biotechnology Drugs for the 21st Century: A CEO's Perspective from a Small Biotech Company
Abbie Celniker, Ph.D. / Eleven Biotherapeutics CEO
Biologics Manufacturing in a Rapidly Changing Environment
Peter Moesta, Ph.D. / Bristol-Myers Squibb Senior Vice President, Biologics Manufacturing & Process Development
Eliminating Interfaces: Process Development Lessons from Aggressive Platform Development
Lars Pampel, Ph.D. / Novartis Pharma AG, Switzerland Group Head, Early Phase Process Development
A Systems Approach to Managing Biomanufacturing Complexity - Genzyme's Allston Plant Case Study
Sandra Poole / Genzyme Senior Vice President Biologics Operations and Allston Site Head
What's New This Year?